Effect of Simvastatin on Pneumonia Prognosis in Elderly Patients
Status:
Unknown status
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
The objective is to assess the effect of simvastatin on immunology, inflammatory, and
coagulation responses, and mortality in elderly with pneumonia based. The primary outcome is
mortality event.
The hypothesis of this study is that simvastatin therapy will reduce mortality in elderly
with pneumonia.